Masimo Net Profit Margin 2010-2023 | MASI
Current and historical net profit margin for Masimo (MASI) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Masimo net profit margin for the three months ending December 31, 2023 was .
| Masimo Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $2.05B | $0.08B | 4.00% |
| 2023-09-30 | $2.12B | $0.09B | 4.21% |
| 2023-06-30 | $2.19B | $0.12B | 5.31% |
| 2023-03-31 | $2.30B | $0.12B | 5.14% |
| 2022-12-31 | $2.04B | $0.14B | 7.08% |
| 2022-09-30 | $1.75B | $0.17B | 9.79% |
| 2022-06-30 | $1.50B | $0.19B | 12.70% |
| 2022-03-31 | $1.24B | $0.22B | 17.93% |
| 2021-12-31 | $1.24B | $0.23B | 18.48% |
| 2021-09-30 | $1.21B | $0.23B | 19.24% |
| 2021-06-30 | $1.18B | $0.22B | 18.95% |
| 2021-03-31 | $1.17B | $0.23B | 19.52% |
| 2020-12-31 | $1.14B | $0.24B | 20.98% |
| 2020-09-30 | $1.10B | $0.22B | 20.24% |
| 2020-06-30 | $1.05B | $0.22B | 21.18% |
| 2020-03-31 | $0.98B | $0.21B | 21.60% |
| 2019-12-31 | $0.94B | $0.20B | 20.87% |
| 2019-09-30 | $0.91B | $0.19B | 20.79% |
| 2019-06-30 | $0.90B | $0.20B | 22.10% |
| 2019-03-31 | $0.88B | $0.20B | 22.44% |
| 2018-12-31 | $0.86B | $0.19B | 22.58% |
| 2018-09-30 | $0.84B | $0.14B | 16.47% |
| 2018-06-30 | $0.83B | $0.12B | 14.29% |
| 2018-03-31 | $0.81B | $0.12B | 14.76% |
| 2017-12-31 | $0.79B | $0.13B | 15.82% |
| 2017-09-30 | $0.78B | $0.36B | 45.85% |
| 2017-06-30 | $0.76B | $0.35B | 46.31% |
| 2017-03-31 | $0.74B | $0.34B | 45.47% |
| 2016-12-31 | $0.71B | $0.31B | 43.76% |
| 2016-09-30 | $0.68B | $0.11B | 16.20% |
| 2016-06-30 | $0.66B | $0.10B | 15.21% |
| 2016-03-31 | $0.65B | $0.09B | 13.91% |
| 2015-12-31 | $0.63B | $0.08B | 13.15% |
| 2015-09-30 | $0.63B | $0.08B | 12.78% |
| 2015-06-30 | $0.62B | $0.08B | 12.32% |
| 2015-03-31 | $0.60B | $0.07B | 11.79% |
| 2014-12-31 | $0.59B | $0.07B | 12.44% |
| 2014-09-30 | $0.57B | $0.06B | 10.76% |
| 2014-06-30 | $0.55B | $0.06B | 11.19% |
| 2014-03-31 | $0.55B | $0.07B | 11.82% |
| 2013-12-31 | $0.55B | $0.06B | 10.62% |
| 2013-09-30 | $0.54B | $0.06B | 11.94% |
| 2013-06-30 | $0.52B | $0.06B | 11.83% |
| 2013-03-31 | $0.51B | $0.06B | 12.35% |
| 2012-12-31 | $0.49B | $0.06B | 12.78% |
| 2012-09-30 | $0.47B | $0.06B | 13.11% |
| 2012-06-30 | $0.46B | $0.06B | 13.76% |
| 2012-03-31 | $0.45B | $0.06B | 13.93% |
| 2011-12-31 | $0.44B | $0.06B | 14.58% |
| 2011-09-30 | $0.43B | $0.07B | 15.24% |
| 2011-06-30 | $0.43B | $0.07B | 15.58% |
| 2011-03-31 | $0.42B | $0.06B | 15.24% |
| 2010-12-31 | $0.41B | $0.07B | 17.98% |
| 2010-09-30 | $0.39B | $0.07B | 18.07% |
| 2010-06-30 | $0.38B | $0.07B | 17.94% |
| 2010-03-31 | $0.36B | $0.07B | 18.46% |
| 2009-12-31 | $0.35B | $0.05B | 15.19% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.196B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.674B | 26.50 |
| Intuitive Surgical (ISRG) | United States | $137.856B | 83.04 |
| DexCom (DXCM) | United States | $51.739B | 78.37 |
| Edwards Lifesciences (EW) | United States | $51.727B | 33.66 |
| IQVIA Holdings (IQV) | United States | $41.749B | 24.22 |
| IDEXX Laboratories (IDXX) | United States | $39.946B | 46.82 |
| Alcon (ALC) | Switzerland | $39.926B | 29.44 |
| STERIS (STE) | Ireland | $21.035B | 24.90 |
| Waters (WAT) | United States | $19.339B | 28.43 |
| Hologic (HOLX) | United States | $17.760B | 19.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.524B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.408B | 77.22 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.801B | 13.77 |
| Sysmex ADR (SSMXY) | Japan | $10.825B | 33.95 |
| Teleflex (TFX) | United States | $9.492B | 14.77 |
| Penumbra (PEN) | United States | $8.139B | 92.51 |
| Globus Medical (GMED) | United States | $6.953B | 20.38 |
| Glaukos (GKOS) | United States | $5.439B | 0.00 |
| TransMedics (TMDX) | United States | $4.192B | 397.75 |
| Integer Holdings (ITGR) | United States | $3.791B | 22.90 |
| LivaNova (LIVN) | United Kingdom | $3.418B | 20.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.229B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.842B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.783B | 19.09 |
| Inari Medical (NARI) | United States | $2.489B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.426B | 20.52 |
| RxSight (RXST) | United States | $2.300B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.976B | 8.62 |
| Alphatec Holdings (ATEC) | United States | $1.899B | 0.00 |
| Veracyte (VCYT) | United States | $1.608B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 95.08 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.897B | 17.45 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.825B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.811B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.646B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.621B | 21.09 |
| IRadimed (IRMD) | United States | $0.553B | 30.99 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.520B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.509B | 0.00 |
| Nevro (NVRO) | United States | $0.423B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
| NeuroPace (NPCE) | United States | $0.382B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 11.74 |
| Sight Sciences (SGHT) | United States | $0.281B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.246B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.213B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.198B | 10.09 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.175B | 0.00 |
| Accuray (ARAY) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.159B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.159B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.092B | 0.00 |
| Neuronetics (STIM) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.065B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 126.00 |
| Yubo Biotech (YBGJ) | China | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| DarioHealth (DRIO) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.018B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |